VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andreas Samson who wrote (21113)	4/22/1999 12:39:00 AM
From: Amots	Read Replies (4) of 23519

AS. From ICOS Bus' Summary: <<For the fiscal year ended 12/31/98, revenues totalled $110.8 million, up from $31.6 million. Net income totalled $31.3 million vs. a loss of $12 million. Revenues reflect the inclusion of a $75 million one-time license of technology fee from Lilly ICOS. Net income also reflects increased investment income. Recent Earnings Announcement For the 3 months ended 03/31/1999, revenues were 16,145; after tax earnings were -7,185. (preliminary; reported in thousands of dollars)>> One time payment are part of the bio's Bus'. The market look at the future, ICOS has one and so does VVUS. In the short term they may pull back (and that why I keep a trading portion),as always. But after learning about what in the pipeline, I have better filling about holding for the long term. Regards Amots

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next